STA
RDUS

Summit Trail Advisors’s Radius Health, Inc. RDUS Stock Holding History

Summit Trail Advisors’s Portfolio RDUS Stock Details RDUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5
Closed – – 1833
2017
Q4 		$0 Buy
+5
New +$157 ﹤0.01% 2129

Other funds holding RDUS

BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Summit Trail Advisors's RDUS Position: Q1 2018 in Review

Summit Trail Advisors sold out of Radius Health, Inc. (RDUS) in Q1 2018, closing a stake of 5 shares.

Summit Trail Advisors first reported a position in RDUS in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 138 funds tracked by Wall St. Rank hold RDUS as of Q1 2018.

  • Summit Trail Advisors reported no remaining Radius Health, Inc. position as of Q1 2018 after selling out during the quarter.
  • Summit Trail Advisors sold 5 Radius Health, Inc. shares in Q1 2018.
  • Summit Trail Advisors first reported a position in Radius Health, Inc. in Q4 2017 and held it in 1 quarter.
  • Summit Trail Advisors's Radius Health, Inc. position peaked at $0 in Q4 2017.
  • 138 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q1 2018.

Based on Summit Trail Advisors's 13F filing for Q1 2018, filed 21 May 2018.